News

Significant £1.2m investment round for Videregen, led by SPARK Impact, to fund clinical trial of trachea replacement technology.

A new antigens formulation against pandemic flu (A H1N1 virus) proved six times more effective than other vaccines.

Scientists will integrate chips mimicking human organ functions into full body system to evaluate drugs.

New spin-out from Cancer Research UK launched with funding from Imperial Innovations, Cambridge Innovation Capital and Johnson & Johnson Development Corporation.

Non-coding DNA raised the risk of breast cancer by affecting the activity of key genes.

Scientists at the University of York are working on a promising new approach for tackling colorectal cancer, the second most common cause of cancer-related death.

Manufacturing biofuels from food crop by-products such as straw could be made quicker and cheaper thanks to a new study led by scientists at the University of York.

New building blocks take microfluidics from flat to 3-D quickly and easily.

Detailing how to achieve consistent feeding regimes for reproducible scale-up.

Areas of the brain that respond to reward and pleasure are linked to the ability of a drug known as butorphanol to relieve itch, according to new research led by Gil Yosipovitch, MD, Professor and Chair of the Department of Dermatology at Temple University School of Medicine (TUSM), and Director of the Temple Itch Center.